H. Nagai

发表

Recent advances in the development of anti-allergic drugs.

H. Nagai, H. Teramachi, Teruo Tuchiya, 2006, Allergology international : official journal of the Japanese Society of Allergology.

Role of Th2 responses in the development of allergen‐induced airway remodelling in a murine model of allergic asthma

Hiroyuki Tanaka, H. Nagai, M. Komai, 2003, British journal of pharmacology.

Prostaglandin D2 as a mediator of allergic asthma.

S. Narumiya, Y. Urade, A. Mizoguchi, 2000, Science.

Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2005, Evidence-based complementary and alternative medicine : eCAM.

Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells.

S. Toda, K. Izuhara, S. Ohta, 2010, International immunology.

Enhancing effect of chlorinated organic solvents on histamine release and inflammatory mediator production.

H. Nagase, K. Ikeda, N. Inagaki, 2008, Toxicology.

Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.

S. Toda, T. Hotokebuchi, T. Kanaji, 2006, The Journal of allergy and clinical immunology.

Arachidonate release and eicosanoid generation by group IIE phospholipase A(2).

M. Gelb, M. Murakami, G. Lambeau, 2002, Biochemical and biophysical research communications.

Prostaglandin as a target molecule for pharmacotherapy of allergic inflammatory diseases.

H. Nagai, 2008, Allergology international : official journal of the Japanese Society of Allergology.

Principle of the bark of Phellodendron amurense to suppress the cellular immune response.

H. Nagai, A. Koda, I. Nishioka, 1994, Planta medica.

Principle of the bark of Phellodendron amurense to suppress the cellular immune response: effect of phellodendrine on cellular and humoral immune responses.

K. Meguro, H. Nagai, A. Koda, 1995, Planta medica.

The effect of substance P on the antigen-induced bronchoconstriction in guinea pigs.

H. Nagai, A. Koda, F. Tsuji, 1990, Journal of pharmacobio-dynamics.

Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80.

N. Inagaki, H. Nagai, N. Shiraishi, 2002, European journal of pharmacology.

Mast cells play a partial role in allergen‐induced subepithelial fibrosis in a murine model of allergic asthma

H. Nagai, M. Komai, T. Masuda, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling

H. Nagai, M. Komai, T. Masuda, 2002, Inflammation Research.

Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis.

K. Kawada, Hiroyuki Tanaka, H. Nagai, 1995, Japanese journal of pharmacology.

Immunomodulatory Effects of CpG Oligodeoxynucleotides on House Dust Mite-Induced Airway Inflammation in Mice

M. Tamari, K. Wakahara, Hiroyuki Tanaka, 2008, International Archives of Allergy and Immunology.

Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease1

E. Green, H. Kubo, S. Toda, 2008, The Journal of Immunology.

Effects of Alpha Tocopherol and Probucol Supplements on Allergen-Induced Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma

H. Tamai, Hiroyuki Tanaka, H. Nagai, 2006, International Archives of Allergy and Immunology.

The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in Rodents

K. Nakashima, Yingfu Li, K. Bacon, 2003, Journal of Pharmacology and Experimental Therapeutics.

Effect of diesel exhaust particles on house dust mite-induced airway eosinophilic inflammation and remodeling in mice.

H. Takano, K. Wakahara, Hiroyuki Tanaka, 2010, Journal of pharmacological sciences.

Recent research and developmental strategy of anti-asthma drugs.

H. Nagai, 2012, Pharmacology & therapeutics.

Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage

H. Hara, M. Shimazawa, H. Nagai, 2005, Evidence-based complementary and alternative medicine : eCAM.

O-Methylated Catechins from Tea Leaves Inhibit Multiple Protein Kinases in Mast Cells1

T. Miyase, T. Kawakami, M. Maeda-Yamamoto, 2004, The Journal of Immunology.

Possible role of prostaglandins in allergic inflammation

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2007 .

Carcinogenic activities of hydroxymethyl derivatives of 4-(dimethylamino)azobenzene in the liver of rats, mice, and hamsters.

K. Kawada, H. Nagai, A. Koda, 1984, Experimental pathology.

Carcinogenicity of 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene in rat liver.

Y. Takahashi, K. Kawada, H. Nagai, 1980, Carcinogenesis.

Inhibition of hypersensitivity reactions by soluble derivatives of baicalein.

H. Nagai, A. Koda, K. Osuga, 1975, Japanese journal of pharmacology.

The immunotoxicity of triphenyltin chloride in mice.

H. Sugiura, H. Nishida, N. Inagaki, 1990, Journal of pharmacobio-dynamics.

Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway.

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2006, Allergology international : official journal of the Japanese Society of Allergology.

Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells.

T. Kato, I. Serizawa, N. Inagaki, 2000, Biochemical pharmacology.

A Kampo formulation: Byakko-ka-ninjin-to (Bai-Hu-Jia-Ren-Sheng-Tang) inhibits IgE-mediated triphasic skin reaction in mice: the role of its constituents in expression of the efficacy.

I. Saiki, K. Terasawa, T. Yamada, 2001, Biological & pharmaceutical bulletin.

Inhibitory mechanisms of glycoprotein fraction derived from Miscanthus sinensis for the immediate phase response of an IgE-mediated cutaneous reaction.

I. Saiki, K. Hase, S. Kadota, 1999, Biological & pharmaceutical bulletin.

A third-phase cutaneous (very late phase) response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice

I. Saiki, K. Terasawa, Y. Shimada, 2000 .

Effect of Shimotsu-to (a Kampo medicine, Si-Wu-Tang) and its constituents on triphasic skin reaction in passively sensitized mice.

I. Saiki, K. Terasawa, Y. Shimada, 1999, Journal of ethnopharmacology.

Different role of IL‐4 in the onset of hapten‐induced contact hypersensitivity in BALB/c and C57BL/6 mice

T. Ochi, K. Kawada, Hiroyuki Tanaka, 2000, British journal of pharmacology.

The effect of Am-80, one of retinoids derivatives on experimental allergic encephalomyelitis in rats.

K. Shudo, T. Wang, S. Matsuura, 2000, Life sciences.

Effect of Am-80, a Synthetic Derivative of Retinoid, on Experimental Arthritis in Mice

K. Shudo, S. Matsuura, H. Nagai, 1999, Pharmacology.

Effect of Am-80, a Retinoid Derivative, on 2,4-Dinitrofluorobenzene-Induced Contact Dermatitis in Mice

K. Shudo, T. Ochi, N. Inagaki, 2000, Pharmacology.

Role of mast cells, eosinophils and IL‐5 in the development of airway hyperresponsiveness in sensitized mice

H. Nagai, H. Tanaka, S. Yamaguchi, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

An Essential Role of Mast Cells in the Development of Airway Hyperresponsiveness in a Murine Asthma Model

I. Serizawa, T. Haba, K. Ishizaka, 2000, The Journal of Immunology.

Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice.

N. Inagaki, H. Nagai, H. Tanaka, 1995, International archives of allergy and immunology.

Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs.

H. Takeda, H. Nagai, H. Tanaka, 1997, Prostaglandins.

The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions.

H. Takeda, N. Inagaki, H. Nagai, 1995, Prostaglandins.

A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice.

H. Ohashi, K. Kawakami, O. Yoshie, 2010, Journal of pharmacological sciences.

Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice.

K. Takatsu, G. Delespesse, Hiroyuki Tanaka, 2004, American journal of respiratory cell and molecular biology.

The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma

Hiroyuki Tanaka, H. Nagai, M. Komai, 2001, Inflammation Research.

Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues.

T. Tsuruo, M. Murakami, M. Naito, 2002, European journal of biochemistry.

Involvement of Bruton’s Tyrosine Kinase in Fc (cid:101) RI-dependent Mast Cell Degranulation and Cytokine Production

F. Alt, S. Galli, O. Witte, 1998 .

Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice.

H. Nagai, H. Tanaka, Y. Maeda, 1998, Life sciences.

The Role of Interleukin‐5 (IL‐5) in Allergic Airway Hyperresponsiveness in Mice

H. Nagai, H. Tanaka, S. Yamaguchi, 1996, Annals of the New York Academy of Sciences.

Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice.

Y. Hitoshi, K. Takatsu, N. Inagaki, 1994, Life sciences.

Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways

H. Nagai, A. Koda, N. Tsuruoka, 1992, British journal of pharmacology.

The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions.

H. Takeda, N. Inagaki, H. Nagai, 1995, Prostaglandins.

Effects of a newly synthesized leukotriene antagonist, NZ-107, on immediate-type hypersensitivity reaction in rats and guinea-pigs.

H. Nagai, A. Koda, T. Miura, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

Effect of antiallergic drugs on interleukin 5-induced eosinophil infiltration of rat airways.

N. Kawada, Hiroyuki Tanaka, H. Nagai, 2002, Biological & pharmaceutical bulletin.

The effect of anti‐IL‐4 monoclonal antibody, rapamycin and interferon‐γ on airway hyperreactivity to acetylcholine in mice

H. Nagai, H. Tanaka, Y. Maeda, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats.

T. Yamada, N. Kawada, N. Inagaki, 2001, Japanese journal of pharmacology.

The effect of a TXA2 receptor antagonist ON-579 on experimental allergic reactions.

H. Takeda, N. Inagaki, H. Nagai, 1995, Prostaglandins, leukotrienes, and essential fatty acids.

Effect of the selective thromboxane A2 receptor antagonist, S-1452, on antigen-induced sustained bronchial hyperresponsiveness.

H. Nagai, A. Arimura, A. Kurosawa, 1994, European journal of pharmacology.

The effect of a novel thromboxane A2 (TXA2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs.

H. Nagai, A. Arimura, A. Koda, 1993, Prostaglandins, leukotrienes, and essential fatty acids.

Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma.

K. Wakahara, Hiroyuki Tanaka, N. Inagaki, 2008, Journal of pharmacological sciences.

Effects of an Amphoteric Antiallergic Agent, HSR-609, on Antigen-Induced Late Phase Nasal Eosinophilia in Brown Norway Rats

H. Nagai, N. Nakamura, K. Musoh, 2000, Pharmacology.

Effects of a New Antiallergic Agent, VUF-K-8788, on Experimental Asthmatic Reactions in Guinea Pigs

T. Yamada, Hiroyuki Tanaka, H. Nagai, 1999, Pharmacology.

Effects of ZCR‐2060 on Allergic Airway Inflammation and Cell Activation in Guinea‐pigs

Kenji Yoshida, T. Omata, H. Nagai, 1994, The Journal of pharmacy and pharmacology.

Antiallergic effects of ZCR-2060: effect on allergic cutaneous reactions and rhinitis models in mice and rats.

T. Omata, H. Nagai, K. Matsuda, 1994, Japanese journal of pharmacology.

Effect of a Novel Anti-Allergic Agent, HSR-609, on Antigen-Induced Airway Hyperresponsiveness in Mice

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2000, Pharmacology.

Role of protein kinase A in the inhibition of human mast cell histamine release by β-adrenergic receptor agonists

I. Serizawa, M. Murata, N. Inagaki, 2002 .

Inhibitory mechanisms of beta-adrenoceptor agonists for immunoglobulin E-mediated experimental allergic reactions in rats.

N. Inagaki, H. Nagai, A. Matsuo, 1997, European journal of pharmacology.

The Roles of Mitogen-Activated Protein Kinase Pathways for Human Cultured Mast Cells

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2001, International Archives of Allergy and Immunology.

Participation of collagenase and elastase in LPS-induced airway hyperresponsiveness in guinea pigs

H. Nagai, A. Koda, F. Tsuji, 1991, Inflammation.

Differential Effect of Antiallergic Drugs on IgE-Mediated Cutaneous Reaction in Passively Sensitized Mice

I. Saiki, K. Terasawa, H. Nagai, 2000, Pharmacology.

Effects of RS-601, a Novel Leukotriene D4/Thromboxane A2 Dual Receptor Antagonist, on Asthmatic Responses in Guinea Pigs

T. Yamada, T. Ohashi, Hiroyuki Tanaka, 2003, Pharmacology.

Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor.

H. Nagai, H. Tanaka, N. Tsuruoka, 1995, Life sciences.

Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity

K. Katagiri, T. Kinashi, S. Narumiya, 2003, Nature Immunology.

The Effects of Inhaled KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor and Thromboxane A2 Receptor, on Allergic Asthmatic Responses in Guinea Pigs

Tsutomu Nakamura, Hiroyuki Tanaka, H. Nagai, 2009, Pharmacology.

Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophilia and remodeling in mice: effect of intratracheal treatment of fluticasone propionate.

K. Shimokata, H. Takano, M. Tamari, 2008, European journal of pharmacology.

Disruption of antigen‐induced airway inflammation and airway hyper‐responsiveness in low affinity neurotrophin receptor p75 gene deficient mice

S. Furukawa, Hiroyuki Tanaka, H. Nagai, 2001, British journal of pharmacology.

Effect of Theophylline on the Production of Interleukin-1β, Tumor Necrosis Factor-α, and Interleukin-8 by Human Peripheral Blood Mononuclear Cells

H. Nagai, T. Yoshimura, E. Usami, 1995 .

Effects of NZ‐107 on Airway Inflammation and Cell Activation in Guinea‐pigs

H. Nagai, A. Koda, T. Iwama, 1993, The Journal of pharmacy and pharmacology.

Effect of murine recombinant interleukin‐5 on bronchial reactivity in guinea‐pigs

H. Nagai, A. Koda, N. Tsuruoka, 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effects of NIP-502 on antigen-induced bronchial responses and allergic reactions in animal models.

H. Takeda, H. Nagai, A. Yamamoto, 1995, Japanese journal of pharmacology.

Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors.

S. Watanabe, T. Nagao, Hiroyuki Tanaka, 1998, General pharmacology.

Effect of repeated antigen inhalation on airway inflammation and bronchial responsiveness to acetylcholine in interleukin-5 transgenic mice

K. Takatsu, N. Kawada, K. Kawada, 2002 .

The effect of ONO-3708, a novel TxA2 receptor antagonist, on U-46619-induced contraction of guinea pig and human tracheal strips in vitro and on bronchoconstriction in guinea pigs in vivo.

N. Inagaki, H. Nagai, A. Koda, 1991, Prostaglandins.

The Effect of Leukotriene D4 Inhalation on the Antigen-Induced Airway Hyperresponsiveness and Inflammation in 5-Lipoxygenase Gene-Deficient Mice

T. Yamada, N. Kawada, Hiroyuki Tanaka, 2001, International Archives of Allergy and Immunology.

The effect of mesoporphyrin on the production of cytokines by inflammatory cells in vitro.

K. Boda, S. Matsuura, H. Nagai, 1999, Japanese journal of pharmacology.

[Present status and future prospects of anti-allergic drugs].

H. Nagai, 2009, Nihon Jibiinkoka Gakkai kaiho.

Antiallergic Action of Betotastine Besilate (TAU-284) in Animal Models: A Comparison with Ketotifen

N. Inagaki, H. Nagai, A. Koda, 1998, Pharmacology.

Effect of TYB-2285 on antigen-induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract.

Y. Kumazawa, H. Nagai, A. Koda, 1997, General pharmacology.

Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs.

H. Nagai, A. Koda, N. Tsuruoka, 1994, Life sciences.

Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells.

M. Murata, Hiroto Akabane, Hiroyuki Tanaka, 2006, Allergology international : official journal of the Japanese Society of Allergology.

Differential Effects of β2-Adrenoceptor Desensitization on the IgE-Dependent Release of Chemical Mediators from Cultured Human Mast Cells

I. Serizawa, N. Inagaki, H. Nagai, 2004 .

Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.

M. Togawa, M. Kiniwa, H. Nagai, 1996, European journal of pharmacology.

Effects of TYB-2285 on the accumulation of eosinophils in the airway induced by antigen exposure in actively sensitized brown Norway rats.

Y. Kumazawa, H. Nagai, A. Koda, 1997, General pharmacology.

Effect of a novel leukotoriene synthesis inhibitor, BAY x1005, on the antigen-and LPS-induced airway hyperresponsiveness in guinea pigs.

H. Takeda, H. Nagai, H. Tanaka, 1996, Prostaglandins.

The role of thromboxane A2 [TxA2] in liver injury in mice.

M. Kasahara, H. Nagai, A. Koda, 1989, Prostaglandins.

The effect of prednisolone on substance P-induced vascular permeability in mice

N. Inagaki, H. Nagai, A. Koda, 1992, Agents and Actions.

Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.

N. Inagaki, H. Nagai, A. Koda, 1990, Journal of pharmacobio-dynamics.

Cysteinyl leukotrienes do not mediate lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs.

H. Nagai, H. Tanaka, T. Uno, 1996, Prostaglandins.

Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice.

K. Takatsu, K. Kawada, N. Inagaki, 2000, The Journal of pharmacology and experimental therapeutics.

Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils.

S. Hayashi, T. Totsuka, H. Nagai, 1997, European journal of pharmacology.

The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells.

Qing Yang, S. Toda, K. Izuhara, 2003, Cytokine.

Effect of Synthetic Retinoid, TAC-101, on Experimental Autoimmune Disease

H. Kagechika, K. Shudo, H. Nagai, 2002, Pharmacology.

Reduction of antigen-induced contraction of sensitized guinea-pig tracheal smooth muscle in vitro by calmodulin inhibitors.

N. Inagaki, H. Nagai, A. Koda, 1986, International archives of allergy and applied immunology.

Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.

N. Inagaki, H. Nagai, A. Koda, 1989, Japanese journal of pharmacology.

Immunopharmacological studies on the anti-allergic actions of traditional Chinese medicines and related components

H. Nagai, 2004 .

Accumulation of Mast Cells in the Lesions and Effects of Antiallergic Drugs on the Patients with Inflammatory Bowel Disease

M. Kurosawa, H. Nagai, 2013 .

[Antiallergic effects of mequitazine. 1. In vitro experiments].

Y. Yanagihara, H. Nagai, A. Koda, 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Inhibition of hypersensitivity reactions by a new drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5').

Y. Yanagihara, H. Nagai, A. Koda, 1976, The Journal of allergy and clinical immunology.

Effect of MX‐68 on airway inflammation and hyperresponsiveness in mice and guinea‐pigs

Hiroto Akabane, Hiroyuki Tanaka, H. Nagai, 2004, The Journal of pharmacy and pharmacology.

Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice

H. Nagai, K. Kitagaki, Y. Takaoka, 1995, Inflammation Research.

Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

S. Hartman, T. Kawakami, E. Kinoshita, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-beta-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazole-[1, 5-a] pyridine (KC-404).

H. Nagai, A. Koda, T. Takizawa, 1983, Japanese journal of pharmacology.

Drugs for the treatment of allergic diseases.

N. Inagaki, H. Nagai, 2001, Japanese journal of pharmacology.

Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs.

H. Nagai, H. Tanaka, T. Uno, 1998, General pharmacology.

Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2010, European journal of pharmacology.

Antiallergic mechanisms of beta-adrenergic stimulants in rats.

N. Inagaki, H. Nagai, A. Koda, 1993, Life sciences.

Selective potentiation of IGE-dependent histamine release from rat peritoneal mast cells by stem cell factor.

N. Inagaki, H. Nagai, H. Kawasaki, 1995, Life sciences.

REVIEW — Current Perspective — Drugs for the Treatment of Allergic Diseases

N. Inagaki, H. Nagai, 2001 .

Antiallergic effect of ZCR-2060: antihistaminic action.

Y. Ikeda, T. Omata, H. Nagai, 1995, Japanese journal of pharmacology.

Immunopharmacological studies on mydocalm and related compounds as an antagonist of slow reacting substance of anaphylaxis (SRS-A).

S. Kohno, H. Nagai, A. Koda, 1983, Journal of pharmacobio-dynamics.

Orally supplemented Lactobacillus acidophilus strain L‐92 inhibits passive and active cutaneous anaphylaxis as well as 2,4‐dinitroflurobenzene and mite fecal antigen induced atopic dermatitis‐like skin lesions in mice

T. Ezaki, Hiroyuki Tanaka, H. Yamashita, 2010, Microbiology and immunology.

FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.

K. Kawada, N. Inagaki, H. Nagai, 1997, The Journal of pharmacology and experimental therapeutics.

Role of T cells in IgE‐dependent triphasic cutaneous reaction caused by dinitrofluorobenzene in the mouse ear: Participation of CD8+ T cells

I. Saiki, T. Ochi, Hiroyuki Tanaka, 2003 .

Effects of prednisolone on the cutaneous reaction and skin barrier function in mice treated with a hapten.

N. Inagaki, H. Nagai, Toshiro Sone, 2003, Biological & pharmaceutical bulletin.

Mechanisms for glucocorticoid inhibition of immediate hypersensitivity reactions in rats.

N. Inagaki, H. Nagai, A. Koda, 1993, Japanese journal of pharmacology.

Studies on the anti-allergic mechanism of glucocorticoids in mice.

N. Inagaki, H. Nagai, A. Koda, 1992, Journal of pharmacobio-dynamics.

Inhibition of IgE antibody formation by n-pentyl alpha-L-sorbopyranoside.

N. Inagaki, H. Nagai, A. Yagi, 1986, Japanese journal of pharmacology.

Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.

N. Inagaki, H. Nagai, Takao Chikumoto, 2006, European journal of pharmacology.

Effect of tranilast on endothelin-induced bronchoconstriction in guinea pigs.

H. Nagai, A. Koda, H. Suda, 1991, Journal of pharmacobio-dynamics.

Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells.

N. Inagaki, S. Choi, H. Nagai, 1989, Journal of pharmacobio-dynamics.

Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines.

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2007, Allergology international : official journal of the Japanese Society of Allergology.

Immunopharmacological Approach to Elucidating the Mechanism of Allergic Inflammation

H. Nagai, 2005 .

Anti-allergic action of glucocorticoids in rats.

H. Nagai, A. Koda, N. Matsuura, 1983, Japanese journal of pharmacology.

Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis.

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2004, Biological & pharmaceutical bulletin.

Role of cyclic 3',5'-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells.

I. Serizawa, H. Saito, N. Inagaki, 1999, The Journal of allergy and clinical immunology.

Pathological studies on nephrotoxic serum nephritis accelerated with rabbit γ-globulin in mice

K. Kawada, H. Nagai, A. Koda, 1989, Inflammation.

Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice

H. Nagai, A. Koda, H. Mori, 1995, Cancer Chemotherapy and Pharmacology.

Inhibitory Effect of HSR‐6071, A New Anti‐allergic Agent, on Experimental Asthma in Rats and Guinea‐pigs

E. Makino, T. Ohashi, H. Nagai, 1990, The Journal of pharmacy and pharmacology.

Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.

H. Kato, Hiroyuki Tanaka, H. Yamashita, 2010, European journal of pharmacology.

Pharmacological Modulation of LPS-Induced MIP-1α Production by Peripheral Blood Mononuclear Cells

N. Inagaki, H. Nagai, H. Mori, 1998, Pharmacology.

Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs.

M. Togawa, H. Nagai, A. Arimura, 1987, Prostaglandins, leukotrienes, and medicine.

Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice.

N. Inagaki, H. Nagai, H. Kawasaki, 1998, Life sciences.

Effect of prednisolone on IgE-dependent biphasic cutaneous reaction in BALB/c mice.

N. Inagaki, H. Nagai, A. Matsuo, 1997, General pharmacology.

The effect of a newly synthesized indazole compound, TAS-3-124, on experimental autoimmune disease.

M. Togawa, Hiroto Akabane, Hiroyuki Tanaka, 2004, Biological & pharmaceutical bulletin.

Prednisolone Inhibits an IgE-Mediated Late-Phase Allergic Cutaneous Reactionby Interfering w ith the Activation of Mast Cells in Mice

N. Inagaki, H. Nagai, I. Yamaguchi, 2001, Pharmacology.

Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice.

N. Inagaki, H. Nagai, I. Yamaguchi, 2000, The Journal of allergy and clinical immunology.

Anti-inflammatory properties of zinc protoporphyrin disodium (Zn−PP−2Na)

H. Nagai, A. Koda, K. Kuwabara, 1992, Agents and Actions.

Pharmacological study of bacterial lipopolysaccharide-induced airway hyperresponsiveness in guinea-pigs.

H. Nagai, A. Koda, F. Tsuji, 1991, Archives internationales de pharmacodynamie et de therapie.

Role of peptide-leukotrienes in liver injury in mice

M. Kasahara, H. Nagai, A. Koda, 1989, Inflammation.

Augmentation of antigen-stimulated allergic responses by a small amount of trichloroethylene ingestion from drinking water.

H. Nagase, K. Ikeda, N. Inagaki, 2008, Regulatory toxicology and pharmacology : RTP.

A small amount of tetrachloroethylene ingestion from drinking water accelerates antigen-stimulated allergic responses.

H. Nagase, K. Ikeda, N. Inagaki, 2008, Immunobiology.

The effects of TYB-2285 and its metabolites on lymphocyte responses in vitro.

Y. Kumazawa, H. Nagai, A. Koda, 1997, General pharmacology.

Possible Role of Nitric Oxide in IgE-Mediated Allergic Cutaneous Reaction in Mice

N. Inagaki, H. Nagai, N. Nakamura, 1997, International Archives of Allergy and Immunology.

Studies on anti-allergic action of AH 21-132, a novel isozyme-selective phosphodiesterase inhibitor in airways.

H. Takeda, H. Nagai, H. Mori, 1995, Japanese journal of pharmacology.

Immunopharmacological Approach to Forssman Shock

H. Nagai, A. Koda, Y. Kurimoto, 1980, Microbiology and immunology.

Overcoming food allergy through acquired tolerance conferred by transfer of Tregs in a murine model

H. Yamashita, N. Inagaki, H. Nagai, 2012, Allergy.

Immunopharmacological studies on the effects of Juzentaihoto and Hochuekkito on experimental autoimmune encephalomyelitis in rats

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2006 .

Active cutaneous anaphylaxis (ACA) in the mouse ear.

N. Inagaki, H. Nagai, A. Koda, 1993, Japanese journal of pharmacology.

Immunopharmacological studies on experimental allergic encephalomyelitis in DA rats.

K. Boda, H. Nagai, K. Kitagaki, 1998, General pharmacology.

Effect of spikelets of Miscanthus sinensis on IgE-mediated biphasic cutaneous reaction in mice.

I. Saiki, K. Hase, S. Kadota, 1998, Planta medica.

An immunopharmacological study of the biphasic allergic skin reaction in mice.

N. Inagaki, H. Nagai, H. Mori, 1995, Biological & pharmaceutical bulletin.

[Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].

H. Nagai, A. Koda, N. Matsuura, 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Augmentation of apoptosis in bronchial exuded rat eosinophils by cyclosporin A.

S. Hayashi, T. Totsuka, H. Nagai, 1996, Biochemical and biophysical research communications.

Characterization of purification-associated reduction in IgE-dependent histamine release from rat peritoneal mast cells

N. Inagaki, H. Nagai, H. Kawasaki, 1995, Inflammation Research.

Recovery of purification-associated reduction in antigen-induced histamine release from rat peritoneal mast cells.

N. Inagaki, H. Nagai, H. Kawasaki, 2001, Biological & pharmaceutical bulletin.

Potentiation of antigen-induced histamine release from rat peritoneal mast cells through a direct interaction between mast cells and non-mast cells.

N. Inagaki, H. Nagai, A. Koda, 1995, Life sciences.

Evaluation and Characterization of Mouse Scratching Behavior by a New Apparatus, MicroAct

H. Nagai, M. Nagao, K. Igeta, 2003, Skin Pharmacology and Physiology.

Evaluation of anti-allergic effects of 1-substituted 2-n-butyl-methylenedioxy indenes.

N. Inagaki, S. Choi, H. Nagai, 1989, Journal of pharmacobio-dynamics.

Synthesis of benzimidazole derivatives as antiallergic agents with 5-lipoxygenase inhibiting action.

T. Inoue, T. Satoh, N. Inagaki, 1999, Chemical & pharmaceutical bulletin.

Effect of mizoribine on effector T cell-mediated immune responses in mice.

H. Nagai, N. Inoue, H. Mori, 1996, Biological & pharmaceutical bulletin.

Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action.

T. Inoue, T. Satoh, N. Inagaki, 2000, Bioorganic & medicinal chemistry.

A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG).

Y. Yanagihara, H. Nagai, A. Koda, 1977, Japanese journal of pharmacology.

Effects of Luteolin and Other Flavonoids on IgE-Mediated Allergic Reactions

N. Inagaki, H. Nagai, M. Kimata, 2000, Planta medica.

Specific suppression of antigen-antibody reactions by a dialysate from Dermatophagoides farinae.

N. Inagaki, H. Nagai, A. Yagi, 1987, Journal of pharmacobio-dynamics.

Immunoglobulin E antibody production against house dust mite, Dermatophagoides farinae, in mice.

N. Inagaki, H. Nagai, A. Koda, 1985, Journal of pharmacobio-dynamics.

Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). II. Effect of CCAq on experimental glomerulonephritis.

H. Nagai, A. Yagi, A. Koda, 1982, Japanese journal of pharmacology.

Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action.

H. Nagai, A. Koda, N. Matsuura, 1982, Japanese journal of pharmacology.

Inhibition of IgE-dependent Mouse Triphasic Cutaneous Reaction by a Boiling Water Fraction Separated from Mycelium of Phellinus linteus

H. Kawagishi, Hiroyuki Tanaka, N. Inagaki, 2005, Evidence-based complementary and alternative medicine : eCAM.

[Pharmacological actions of baicalin and baicalein. 3. Action on experimental asthma].

H. K. Lauw, H. Nagai, A. Koda, 1970, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Comparative study of IgG1 and IgE antibody mediated homologous PCA in the mouse ear. Lack of cross-desensitization of IgG1 antibody mediated PCA to IgE antibody mediated PCA.

N. Inagaki, H. Nagai, A. Koda, 1989, International archives of allergy and applied immunology.

[Anti-allergic actions of traditional oriental medicine--actions against types I and IV hypersensitivity reactions].

H. Nagai, A. Koda, N. Matsuura, 1982, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[Pharmacological actions of baicalin and baicalein. 2. On passive anaphylaxis].

H. Nagai, A. Koda, H. Wada, 1970, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice.

M Nagao, N. Inagaki, H. Nagai, 1999, European journal of pharmacology.

[Regulation of allergic responses by Kampo medicines].

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2008, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Role of hyaluronidase in immediate hypersensitivity reaction.

H. Nagai, A. Koda, K. Sakamoto, 1980, Immunopharmacology.

Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells.

S. Watanabe, H. Nagai, T. Yoshimura, 1996, Chemotherapy.

Inhibitory effects of Piper betle on production of allergic mediators by bone marrow-derived mast cells and lung epithelial cells.

M. Wirotesangthong, Hiroyuki Tanaka, N. Inagaki, 2008, International immunopharmacology.

Ca2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells.

I. Serizawa, N. Inagaki, H. Nagai, 1999, Biochemical and biophysical research communications.

Immunopharmacological studies on experimental glomerulonephritis.

H. Nagai, A. Koda, H. Mori, 1983, International journal of immunopharmacology.

Liver injury model in mice for immunopharmacological study.

M. Kasahara, H. Nagai, A. Koda, 1989, Japanese journal of pharmacology.

Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.

H. Nagai, A. Koda, H. Suda, 1992, Japanese journal of pharmacology.

A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.

H. Yamazaki, H. Nagai, A. Koda, 1986, Japanese journal of cancer research : Gann.

Adhesion Molecules

K. Shudo, H. Nagai, K. Bouda, 2014, Inflammation Research.

Characterization of skin inflammation induced by repeated exposure of toluene, xylene, and formaldehyde in mice

Hiroyuki Tanaka, H. Yamashita, N. Inagaki, 2011, Environmental toxicology.

Evaluation of anti-scratch properties of oxatomide and epinastine in mice.

N. Inagaki, H. Nagai, H. Kawasaki, 2000, European journal of pharmacology.

[Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma].

N. Inagaki, H. Nagai, A. Koda, 1986, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production

F. Alt, S. Galli, O. Witte, 1998, The Journal of experimental medicine.

Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.

M. Croft, T. Kawakami, S. Salek-Ardakani, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

S. Narumiya, Y. Sugimoto, A. Ichikawa, 2005, Nature Immunology.

Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison.

G. Tsujimoto, M. Ebisawa, M. Tamari, 2002, Blood.

Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.

S. Watanabe, T. Nagao, Hiroyuki Tanaka, 1997, General pharmacology.

Scratching Behavior in Various Strains of Mice

N. Inagaki, H. Nagai, H. Kawasaki, 2001, Skin Pharmacology and Physiology.

A new murine model of allergic rhinitis by repeated intranasal Cry j 1 challenge.

T. Yamaji, H. Nagai, K. Kino, 2008, Biomedical research.

Comparative study of 1.5-hour and 48-hour homologous passive cutaneous anaphylaxis in the mouse ear.

N. Inagaki, H. Nagai, A. Koda, 1989, Journal of pharmacobio-dynamics.

The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs.

H. Nagai, A. Arimura, A. Koda, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

Role of thromboxane (Tx) A2 in guinea pig Forssman shock and the effect of OKY-046, Tx A2 synthetase inhibitor.

N. Inagaki, H. Nagai, A. Koda, 1987, Prostaglandins, leukotrienes, and medicine.

The effect of 6-amidino-2-naphtyl-4-guanidinobenzoate dimethane sulfonate (FUT-175) on experimental glomerulonephritis in mice.

N. Inagaki, H. Nagai, A. Koda, 1984, Japanese journal of pharmacology.

[Combined effect of Scutellaria baicalensis Georgi and anti-asthmatic drugs].

H. Nagai, A. Koda, S. Katayama, 1972, Arerugi = [Allergy].

Anti-allergic effects of ketanserin on animal models of allergic reactions.

H. Nagai, A. Koda, T. Miura, 1990, Archives internationales de pharmacodynamie et de therapie.

Enhancement of immediate allergic reactions by trichloroethylene ingestion via drinking water in mice.

H. Nagase, N. Inagaki, H. Nagai, 2010, The Journal of toxicological sciences.

From Molecular Science to the Treatment of Allergy

M. Manns, Jane Wilkinson, P. Hufnagl, 1999, International Archives of Allergy and Immunology.

Immunopharmacological studies of sodium copper chlorphyllin (SCC).

H. Nagai, A. Koda, M. Daikoku, 1983, Japanese journal of pharmacology.

Experimental glomerulonephritis in mice as a model for immunopharmacological studies.

H. Nagai, A. Koda, T. Takizawa, 1982, Japanese journal of pharmacology.

Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten.

K. Kawada, N. Inagaki, H. Nagai, 1997, The Journal of allergy and clinical immunology.

Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro.

M. Iinuma, L. Baolin, Hiroyuki Tanaka, 2004, Planta medica.

The effects of mesoporphyrin on experimental arthritis in mice

H. Nagai, N. Matsuura, H. Mori, 1996, Inflammation Research.

The model of arthritis induced by superantigen in mice.

H. Nagai, H. Mori, Y. Takaoka, 1995, Life sciences.

Homologous passive cutaneous anaphylaxis in various strains of mice.

N. Inagaki, H. Nagai, A. Koda, 1987, International archives of allergy and applied immunology.

Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice.

S. Narumiya, Hiroyuki Tanaka, H. Nagai, 2003, American journal of respiratory cell and molecular biology.

A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions.

N. Inagaki, H. Nagai, A. Arimura, 1991, International archives of allergy and applied immunology.

Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.

S. Matsuura, H. Nagai, Y. Takaoka, 1997, Japanese Journal of Pharmacology.

Effects of MKS-492 on antigen-induced bronchoconstriction and allergic reaction in guinea pigs and rats.

N. Inagaki, H. Nagai, A. Koda, 1994, Japanese journal of pharmacology.

Psychosocial stress enhances IgE‐mediated triphasic cutaneous reaction in mice: Antagonism by Yokukan‐san (a Kampo medicine) and diazepam

I. Saiki, K. Terasawa, H. Nagai, 2002 .

Effect of Chinese blended medicine, Saiboku-to, on type IV allergic reaction.

H. Nagai, A. Koda, N. Matsuura, 1983, Arerugi = [Allergy].

[Evaluation of drugs for the treatment of atopic dermatitis in mice].

N. Inagaki, H. Nagai, 2006, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Effect of rapeseed and dietary oils on the mean survival time of stroke-prone spontaneously hypertensive rats.

H. Okuyama, S. Watanabe, H. Nagai, 1996, Biological & pharmaceutical bulletin.

Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of drug-induced allergic hepatitis.

H. Nagai, S. Nakano, T. Yoshimura, 1994, Biological & pharmaceutical bulletin.

Effect of Am-80, A Novel Retinoid Derivative, On Contact Hypersensitivity Caused by Repeated Applications of Hapten in Mice

K. Shudo, T. Ochi, N. Inagaki, 2001 .

High rate of IgE-mediated histamine release from rat mesenteric mast cells.

N. Inagaki, H. Nagai, H. Kawasaki, 2001, Experimental animals.

Augmentation of allergic inflammation in prostanoid IP receptor deficient mice

S. Narumiya, Hiroyuki Tanaka, N. Inagaki, 2002, British journal of pharmacology.

Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs.

H. Nagai, S. Yamaguchi, T. Iwama, 1994, Prostaglandins, leukotrienes, and essential fatty acids.

Pharmacological model for airway hypersensitivity produced by propranolol and reserpine in guinea pigs.

N. Inagaki, H. Nagai, A. Koda, 1993, Prostaglandins, leukotrienes, and essential fatty acids.

Effect of cinnarizine on IgE antibody mediated allergic reaction in mice and rats.

N. Inagaki, H. Nagai, A. Koda, 1986, Journal of Pharmacobio-Dynamics.

Effect of cinnarizine on IgE antibody‐mediated experimental allergic reactions in guinea pigs

N. Inagaki, S. Choi, H. Nagai, 1987, Allergy.

Pharmacological characterization of mouse ear PCA.

N. Inagaki, H. Nagai, A. Koda, 1986, International archives of allergy and applied immunology.

Inhibition of syk activity and degranulation of human mast cells by flavonoids.

H. Nagai, H. Tsujishita, T. Kokubo, 2003, Biological & pharmaceutical bulletin.

Integrin αIIbβ3 Induces the Adhesion and Activation of Mast Cells through Interaction with Fibrinogen1

T. Kitamura, K. Eto, M. Maeda-Yamamoto, 2006, The Journal of Immunology.

TNF-α participates in an IgE-mediated cutaneous reaction in mast cell deficient, WBB6F1-W/Wv mice

N. Inagaki, H. Nagai, A. Matsuo, 1996, Inflammation Research.

Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.

N. Inagaki, H. Nagai, A. Koda, 1987, International archives of allergy and applied immunology.

Interferon-beta prevents antigen-induced bronchial inflammation and airway hyperreactivity in mice.

H. Nagai, H. Tanaka, M. Shichijo, 1997, Pharmacology.

Cyclic AMP-elevating agents inhibit mite-antigen-induced IL-4 and IL-13 release from basophil-enriched leukocyte preparation.

N. Inagaki, H. Nagai, M. Shichijo, 1997, International archives of allergy and immunology.

IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.

K. Takagi, M. Togawa, N. Inagaki, 1999, Japanese Journal of Pharmacology.

Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats.

S. Choi, H. Nagai, A. Koda, 1987, Journal of Pharmacobio-Dynamics.

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

T. Yamashima, H. Hara, M. Shimazawa, 2005, Brain Research.

Cellular Arachidonate-releasing Function and Inflammation-associated Expression of Group IIF Secretory Phospholipase A2 *

M. Gelb, M. Murakami, G. Lambeau, 2002, Journal of Biological Chemistry.

Effect of TYB-2285 on passive cutaneous anaphylaxis in rats.

Y. Kumazawa, H. Nagai, A. Koda, 1997, General pharmacology.

Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines.

I. Morishima, H. Nagai, T. Yoshimura, 1995, Biological & pharmaceutical bulletin.

Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mouse models for the development of remedies for human allergic dermatitis.

N. Inagaki, H. Nagai, 2009, Journal of pharmacological sciences.

Mouse ear PCA as a model for evaluating antianaphylactic agents.

N. Inagaki, H. Nagai, A. Koda, 1985, International archives of allergy and applied immunology.

Effect of OKY-046 and ONO-3708 on liver injury in mice.

M. Kasahara, H. Nagai, A. Koda, 1989, Japanese journal of pharmacology.

Effect of a newly synthesized leukotriene antagonist, (E)-2,2-diethyl-3'-2-2-(4-isopropyl) thiazolyl ethenyl succinanilic acid (MCI-826), on immunological liver injury and nephritis in mice.

H. Nagai, A. Koda, T. Miura, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

The effects of thromboxane A2 inhibitors (OKY-046 and ONO-3708) and leukotriene inhibitors (AA-861 and LY-171883) on CCl4-induced chronic liver injury in mice.

M. Kasahara, H. Nagai, A. Koda, 1990, Prostaglandins, leukotrienes, and essential fatty acids.

[Effect of neurotropin (NSP) on allergic reactions (author's transl)].

T. Yamada, N. Inagaki, H. Nagai, 1981, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Transient receptor potential vanilloid 1 - a polymodal nociceptive receptor - plays a crucial role in formaldehyde-induced skin inflammation in mice.

M. Tominaga, Hiroyuki Tanaka, H. Yamashita, 2012, Journal of pharmacological sciences.

Induction of PYPAF1 during in vitro maturation of mouse mast cells.

T. Moon, M. Murakami, T. Sugiki, 2003, Journal of biochemistry.

Histamine release from rat neutrophils and mast cells as induced by ionophore--a pharmacological approach--.

H. Nagai, A. Koda, 1979, Japanese journal of pharmacology.

Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice.

K. Kawada, H. Nagai, Y. Takaoka, 1998, General pharmacology.

[Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].

H. Nagai, A. Koda, H. Fujimura, 1980, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Effect of KE-298 on experimental arthritis in mice.

K. Kawada, H. Nagai, H. Mori, 1996, Pharmacology.

Anti-inflammatory activities of Brazilian Licorice (Periandra mediterranea) extract

M. Iinuma, T. Nakayama, N. Inagaki, 2004 .

Inhibition of Passive Cutaneous Anaphylaxis-Associated Scratching Behavior by μ-Opioid Receptor Antagonists in ICR Mice

N. Inagaki, H. Nagai, H. Kawasaki, 2000, International Archives of Allergy and Immunology.

Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen.

T. Kitamura, K. Eto, M. Maeda-Yamamoto, 2006, Journal of immunology.

Extracellular phospholipase A2 and histamine release from rat peritoneal mast cells.

M. Kondo, N. Inagaki, H. Nagai, 1991, International archives of allergy and applied immunology.

Immunopharmacological studies of wen-qing-yin, a Chinese blended medicine: effects on type IV allergic reactions and humoral antibody production.

H. Nagai, A. Koda, N. Matsuura, 1988, International journal of immunopharmacology.

Inhibit Multiple Protein Kinases in Mast-Methylated Catechins from Tea Leaves

T. Miyase, T. Kawakami, M. Maeda-Yamamoto, 2004 .

Diagnosis of drug allergy by the lymphocyte stimulation test with the MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay.

H. Nagai, T. Yoshimura, C. Kurita, 1993, Biological & pharmaceutical bulletin.

Effect of vitamin E on IgE antibody formation in mice.

N. Inagaki, H. Nagai, A. Koda, 1985, Journal of pharmacobio-dynamics.

[The role of lipid mediators in allergic diseases].

H. Nagai, 2007, Arerugi = [Allergy].

Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia

S. Akira, H. Hara, S. Uematsu, 2010, Neuroscience.

The effect of gomisin A on immunologic liver injury in mice.

M. Aburada, H. Nagai, A. Koda, 1989, Planta medica.

Effects of luteolin, quercetin and baicalein on immunoglobulin E‐mediated mediator release from human cultured mast cells

I. Serizawa, N. Inagaki, H. Nagai, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Peritoneal mast cell hyperplasia in rats after IgE antibody-antigen interaction.

N. Inagaki, H. Nagai, H. Kawasaki, 1995, Experimental animals.

Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.

N. Inagaki, H. Nagai, A. Koda, 1990, Pharmacology.

[Effect of alpha-mercaptopropionylglycine (alpha-MPG) and sodium dipropylacetate (DPA) on antibody formation (II). Immunosuppression induced by carcinostatic agents and glucocorticoid (author's transl)].

H. Nagai, A. Koda, H. Mori, 1978, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells.

S. Watanabe, T. Nagao, N. Inagaki, 1997, Pharmacology.

Mechanism for Macrophage Activation against Corynebacterium parvum—Participation of T Cells and Its Lymphokines

H. Nagai, A. Koda, M. Mihara, 1994, Microbiology and immunology.

Interleukin-1B Induces Interleukin-6 Production through the Production of Prostaglandin E2 in Human Osteoblasts, MG-63 Cells

H. Nagai, S. Niwa, Y. Takaoka, 1999 .

Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E(2) in human osteoblasts, MG-63 cells.

H. Nagai, S. Niwa, Y. Takaoka, 1999, Journal of biochemistry.

Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterization

N. Inagaki, H. Nagai, N. Nakamura, 1998 .

The effect of anti-tumor necrosis factor (TNF)-alpha monoclonal antibody on allergic cutaneous late phase reaction in mice.

N. Inagaki, H. Nagai, T. Sakurai, 1995, Life sciences.

Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia

S. Akira, H. Hara, S. Uematsu, 2010, Neuroscience.

A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice.

H. Ohashi, K. Kawakami, O. Yoshie, 2010, Journal of pharmacological sciences.

The effect of TRK-530 on experimental arthritis in mice.

H. Nagai, H. Mori, Y. Takaoka, 1997, Biological & pharmaceutical bulletin.

Inhibition of vascular permeability increase in mice. An additional anti-allergic mechanism of glucocorticoids.

N. Inagaki, H. Nagai, A. Koda, 1989, International Archives of Allergy and Applied Immunology.

Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.

M. Croft, T. Kawakami, J. Kitaura, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.

N. Inagaki, H. Nagai, A. Koda, 1984, Journal de pharmacologie.

VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.

H. Timmerman, T. Kanke, N. Inagaki, 2001, Japanese journal of pharmacology.

The susceptibility of experimental glomerulonephritis in six different strains of mice.

H. Nagai, A. Koda, M. Nakazawa, 1985, Journal of pharmacobio-dynamics.

Effects of Sho-seiryu-to (Xiao-Qing-Long-Tang) on experimental allergic reactions.

T. Ochi, H. Takeda, N. Inagaki, 2000 .

Effects of a new antiallergic drug, VUF-K-8788, on infiltration of lung parenchyma by eosinophils in guinea pigs and eosinophil-adhesion to human umbilical vein endothelial cells (HUVEC).

I. Saiki, H. Nagai, T. Takizawa, 2001, Biological & pharmaceutical bulletin.